ArticlePharmaceutics2020

Evaluating the Therapeutic Efficacy of Mono- and Bivalent Affibody-Based Fusion Proteins Targeting HER3 in a Pancreatic Cancer Xenograft Model.

Charles Dahlsson Leitao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.